These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study. Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771 [TBL] [Abstract][Full Text] [Related]
24. Effects of Fingolimod and Natalizumab on Brain T1-/T2-Weighted and Magnetization Transfer Ratios: a 2-Year Study. Preziosa P; Storelli L; Meani A; Moiola L; Rodegher M; Filippi M; Rocca MA Neurotherapeutics; 2021 Apr; 18(2):878-888. PubMed ID: 33483938 [TBL] [Abstract][Full Text] [Related]
25. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis. Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955 [TBL] [Abstract][Full Text] [Related]
26. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study. Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524 [TBL] [Abstract][Full Text] [Related]
27. Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging. Margoni M; Villani U; Silvestri E; Franciotta S; Anglani MG; Causin F; Rinaldi F; Perini P; Bertoldo A; Gallo P Mult Scler Relat Disord; 2022 Feb; 58():103396. PubMed ID: 35216779 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis. Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784 [TBL] [Abstract][Full Text] [Related]
29. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis. Pietroboni AM; Colombi A; Contarino VE; Russo FML; Conte G; Morabito A; Siggillino S; Carandini T; Fenoglio C; Arighi A; De Riz MA; Arcaro M; Sacchi L; Fumagalli GG; Bianchi AM; Triulzi F; Scarpini E; Galimberti D Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783 [TBL] [Abstract][Full Text] [Related]
30. Microstructural changes in normal-appearing white matter in male sleep apnea patients are reversible after treatment: A pilot study. Salsone M; Caligiuri ME; Castronovo V; Canessa N; Marelli S; Quattrone A; Quattrone A; Ferini-Strambi L J Neurosci Res; 2021 Oct; 99(10):2646-2656. PubMed ID: 34197014 [TBL] [Abstract][Full Text] [Related]
31. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. Stebbins GT; Smith CA; Bartt RE; Kessler HA; Adeyemi OM; Martin E; Cox JL; Bammer R; Moseley ME J Acquir Immune Defic Syndr; 2007 Dec; 46(5):564-73. PubMed ID: 18193498 [TBL] [Abstract][Full Text] [Related]
32. The association between white matter tract structural connectivity and information processing speed in relapsing-remitting multiple sclerosis. Chylińska M; Karaszewski B; Komendziński J; Wyszomirski A; Hałas M; Szurowska E; Sabisz A Neurol Sci; 2023 Sep; 44(9):3221-3232. PubMed ID: 37103603 [TBL] [Abstract][Full Text] [Related]
33. Diffusion tensor imaging of normal-appearing cervical spinal cords in patients with multiple sclerosis: Correlations with clinical evaluation and cerebral diffusion tensor imaging changes. Preliminary experience. Wolańczyk M; Bladowska J; Kołtowska A; Pokryszko-Dragan A; Podgórski P; Budrewicz S; Sąsiadek M Adv Clin Exp Med; 2020 Apr; 29(4):441-448. PubMed ID: 32369275 [TBL] [Abstract][Full Text] [Related]
34. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study. Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038 [TBL] [Abstract][Full Text] [Related]
35. Fatigue in multiple sclerosis: The contribution of occult white matter damage. Bisecco A; Caiazzo G; d'Ambrosio A; Sacco R; Bonavita S; Docimo R; Cirillo M; Pagani E; Filippi M; Esposito F; Tedeschi G; Gallo A Mult Scler; 2016 Nov; 22(13):1676-1684. PubMed ID: 26846989 [TBL] [Abstract][Full Text] [Related]
36. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI. Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672 [TBL] [Abstract][Full Text] [Related]
37. A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T. Gratsias G; Kapsalaki E; Kogia S; Dardiotis E; Tsimourtou V; Lavdas E; Kousi E; Pelekanou A; Hadjigeorgiou GM; Fezoulidis I Acta Neurol Belg; 2015 Jun; 115(2):111-6. PubMed ID: 25073775 [TBL] [Abstract][Full Text] [Related]
38. Diffusion Tensor Imaging Reveals Microstructural Heterogeneity of Normal-Appearing White Matter and Related Cognitive Dysfunction in Glioma Patients. Jütten K; Mainz V; Gauggel S; Patel HJ; Binkofski F; Wiesmann M; Clusmann H; Na CH Front Oncol; 2019; 9():536. PubMed ID: 31293974 [TBL] [Abstract][Full Text] [Related]
39. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2. Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529 [TBL] [Abstract][Full Text] [Related]
40. Effects of fingolimod on focal and diffuse damage in patients with relapsing-remitting multiple sclerosis - The "EVOLUTION" study. Filippi M; Pagani E; Turrini R; Bartezaghi M; Brescia Morra V; Borriello G; Torri Clerici V; Mirabella M; Pasquali L; Patti F; Totaro R; Gallo P; Rocca MA; J Neurol; 2024 Sep; 271(9):6181-6196. PubMed ID: 39073436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]